Nika Pharmaceuticals (NIKA) Consolidated Net Income (2021 - 2026)
Nika Pharmaceuticals (NIKA) recorded Consolidated Net Income of -$10,143 in Q3 2023, compared with -$6,339 a year earlier.
Powered by 
Analysis
Nika Pharmaceuticals (NIKA) Consolidated Net Income (2021 - 2026) Analysis & Trends
On a TTM basis, Nika Pharmaceuticals' Consolidated Net Income came in at -$72,569 as of Sep 30, 2023; for FY2022, it came in at -$3.18 million.
- Across earlier years, Consolidated Net Income came in at -$14,712 in FY2021.
- Quarterly Consolidated Net Income has ranged from -$3.16 million in Q2 2022 to $6,316 in Q1 2022 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$27,806 (Q2 2023), -$19,570 (Q1 2023) and -$15,050 (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Nika Pharmaceuticals | 369.14 Mn | 369.13 Mn | - | -13,023.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -13,023.00 |
| Jun 30, 2026 | -19,694.00 |
| Mar 31, 2026 | -13,359.00 |
| Dec 31, 2025 | -37,089.00 |
| Sep 30, 2025 | -7,982.00 |
| Jun 30, 2025 | -18,381.00 |
| Mar 31, 2025 | -12,945.00 |
| Dec 31, 2024 | -12,452.00 |
| Sep 30, 2024 | -8,367.00 |
| Jun 30, 2024 | -22,457.00 |
| Mar 31, 2024 | -45,952.00 |
| Dec 31, 2023 | -7,314.00 |
| Sep 30, 2023 | -10,143.00 |
| Jun 30, 2023 | -10,143.00 |
| Mar 31, 2023 | -19,570.00 |
| Dec 31, 2022 | -15,050.00 |
| Sep 30, 2022 | -6,339.00 |
| Jun 30, 2022 | -3.16 Mn |
| Mar 31, 2022 | 6,316.00 |
| Dec 31, 2021 | -26,124.00 |
API Access
Nika Pharmaceuticals Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=NIKA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "NIKA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=NIKA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();